$NXDT
NEXPOINT DIVERSIFIED REAL ESTATE TRUST Stock $nxdt

$nxdt Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000135611523000007 Filed on May 12, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$13.88M	$14.87M	$14.72M
YoY Change	-83.07%	1.03%
Cost Of Revenue	$3.100M	$3.912M
YoY Change	-72.19%
Gross Profit	$10.70M	$10.95M
YoY Change	-84.89%
Gross Profit Margin	77.09%	73.68%
Selling, General & Admin	$4.600M	$3.596M
YoY Change	2385.81%
% of Gross Profit	42.99%	32.83%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.300M	$3.524M
YoY Change
% of Gross Profit	21.5%	32.17%
Operating Expenses	$10.80M	$8.626M
YoY Change	1579.44%
Operating Profit	$27.00K	$2.328M
YoY Change	-99.96%
Interest Expense	$3.762M	$3.462M	$323.0K
YoY Change	-93.76%	971.83%
% of Operating Profit	13933.33%	148.71%
Other Income/Expense, Net
YoY Change
Pretax Income	-$13.60M	-$18.72M
YoY Change	-110.42%
Income Tax	$300.0K	$800.0K
% Of Pretax Income
Net Earnings	-$13.87M	-$19.52M	$58.28M
YoY Change	-110.63%	-133.5%
Net Earnings / Revenue	-99.91%	-131.31%	396.03%
Basic Earnings Per Share	-$0.40	-$0.56
Diluted Earnings Per Share	-$0.40	-$0.56
COMMON SHARES
Basic Shares Outstanding	37.17M shares	37.17M shares
Diluted Shares Outstanding	37.17M shares	37.17M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$723.2M	$736.2M
YoY Change	14238.11%
Cash & Equivalents	$10.59M	$8.348M	$36.15M
Short-Term Investments	$712.7M	$727.9M
Other Short-Term Assets	$7.500M	$4.959M
YoY Change	602.72%
Inventory
Prepaid Expenses
Receivables	$9.800M	$7.211M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$27.90M	$20.52M
YoY Change	247.32%
LONG-TERM ASSETS
Property, Plant & Equipment	$266.6M	$267.8M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$69.59M	$69.85M
YoY Change	-93.84%
Other Assets	$36.20M	$38.82M
YoY Change
Total Long-Term Assets	$1.146B	$1.171B
YoY Change	1.42%
TOTAL ASSETS
Total Short-Term Assets	$27.90M	$20.52M
Total Long-Term Assets	$1.146B	$1.171B
Total Assets	$1.174B	$1.191B
YoY Change	3.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.500M	$12.51M
YoY Change	706.86%
Accrued Expenses	$3.500M	$2.259M
YoY Change	2999.81%
Deferred Revenue
YoY Change
Short-Term Debt	$400.0K	$422.0K
YoY Change	-97.5%
Long-Term Debt Due	$5.000M	$8.000M
YoY Change
Total Short-Term Liabilities	$18.40M	$36.10M
YoY Change	-25.53%
LONG-TERM LIABILITIES
Long-Term Debt	$178.4M	$157.9M
YoY Change
Other Long-Term Liabilities	$5.300M	$5.656M
YoY Change
Total Long-Term Liabilities	$183.7M	$163.6M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.40M	$36.10M
Total Long-Term Liabilities	$183.7M	$163.6M
Total Liabilities	$202.2M	$199.7M
YoY Change	718.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$28.99M	-$8.304M
YoY Change	-125.37%
Common Stock	$37.00K	$37.00K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$971.3M	$991.6M	$965.9M
YoY Change
Total Liabilities & Shareholders Equity	$1.174B	$1.191B
YoY Change	3.16%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$13.87M	-$19.52M	$58.28M
YoY Change	-110.63%	-133.5%
Depreciation, Depletion And Amortization	$2.300M	$3.524M
YoY Change
Cash From Operating Activities	-$21.30M	$505.0K	$47.09M
YoY Change	-155.15%	-98.93%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$10.40M	$8.234M
YoY Change
Cash From Investing Activities	$10.40M	$8.234M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid			$5.119M
YoY Change
Common Stock Issuance & Retirement, Net			$1.526M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	11.00M	-$12.59M	-$13.62M
YoY Change	-130.34%	-7.59%
NET CHANGE
Cash From Operating Activities	-21.30M	$505.0K	$47.09M
Cash From Investing Activities	10.40M	$8.234M
Cash From Financing Activities	11.00M	-$12.59M	-$13.62M
Net Change In Cash	100.0K	-$3.848M	$33.47M
YoY Change	-95.77%	-111.5%
FREE CASH FLOW
Cash From Operating Activities	-$21.30M	$505.0K	$47.09M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001356115
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-32921
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	NexPoint Diversified Real Estate Trust
CY2023Q1	us-gaap	Land Land	47708000	usd
CY2022Q4	us-gaap	Land Land	47708000	usd
CY2023Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	174471000	usd
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	80-0139099
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	300 Crescent Court
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 700
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75201
CY2023Q1	dei	City Area Code CityAreaCode	214
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	276-6300
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37171807	shares
CY2022Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	174469000	usd
CY2023Q1	us-gaap	Rental Properties RentalProperties	10979000	usd
CY2022Q4	us-gaap	Rental Properties RentalProperties	10979000	usd
CY2023Q1	us-gaap	Development In Process DevelopmentInProcess	44894000	usd
CY2022Q4	us-gaap	Development In Process DevelopmentInProcess	39731000	usd
CY2023Q1	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	362000	usd
CY2022Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	354000	usd
CY2023Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	278414000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	273241000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	10603000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	7158000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	267811000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	266083000	usd
CY2023Q1	us-gaap	Marketable Securities MarketableSecurities	727856000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	754910000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	69852000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	70656000	usd
CY2023Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	66384000	usd
CY2022Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	67711000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8348000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13360000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	36453000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	35289000	usd
CY2023Q1	us-gaap	Receivables From Customers ReceivablesFromCustomers	1919000	usd
CY2022Q4	us-gaap	Receivables From Customers ReceivablesFromCustomers	1903000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	4959000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	6441000	usd
CY2023Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	5292000	usd
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	4302000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2363000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2247000	usd
CY2023Q1	us-gaap	Assets Assets	1191237000	usd
CY2022Q4	us-gaap	Assets Assets	1222902000	usd
CY2023Q1	us-gaap	Loans Payable LoansPayable	143918000	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	144414000	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	21250000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	24250000	usd
CY2023Q1	srt	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	736000	usd
CY2022Q4	srt	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	2624000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	12512000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	13865000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	11641000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	10720000	usd
CY2023Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	1131000	usd
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	254000	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1128000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1115000	usd
CY2023Q1	us-gaap	Security Deposit Liability SecurityDepositLiability	422000	usd
CY2022Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	416000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	991581000	usd
CY2023Q1	us-gaap	Advance Rent AdvanceRent	1150000	usd
CY2022Q4	us-gaap	Advance Rent AdvanceRent	1273000	usd
CY2023Q1	nxdt	Intangible Lease Liabilities Net IntangibleLeaseLiabilitiesNet	5656000	usd
CY2022Q4	nxdt	Intangible Lease Liabilities Net IntangibleLeaseLiabilitiesNet	6027000	usd
CY2023Q1	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	112000	usd
CY2022Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	112000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	199656000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	205070000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4800000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4800000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3359593	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3359593	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3359593	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3359593	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	3000	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	3000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37171807	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37171807	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37171807	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37171807	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	37000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	37000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	999845000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	999845000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8304000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	17947000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1017832000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1191237000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1222902000	usd
CY2023Q1	us-gaap	Lease Income LeaseIncome	4720000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2018000	usd
CY2023Q1	us-gaap	Investment Income Dividend InvestmentIncomeDividend	8119000	usd
CY2023Q1	us-gaap	Other Income OtherIncome	9000	usd
CY2023Q1	us-gaap	Revenues Revenues	14866000	usd
CY2023Q1	nxdt	Property Operating Expenses PropertyOperatingExpenses	1506000	usd
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	171000	usd
CY2023Q1	us-gaap	Taxes Excluding Income And Excise Taxes TaxesExcludingIncomeAndExciseTaxes	1357000	usd
CY2023Q1	nxdt	Advisory And Administrative Fees AdvisoryAndAdministrativeFees	3578000	usd
CY2023Q1	nxdt	Conversion Expense ConversionExpense	163000	usd
CY2023Q1	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	3524000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	12538000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	2328000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	3462000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-76000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-18640000	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	1135000	usd
CY2023Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-18715000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	806000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-19521000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1155000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20676000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37172000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37172000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2022Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	14715000	usd
CY2022Q1	us-gaap	Noninterest Expense Investment Advisory Fees NoninterestExpenseInvestmentAdvisoryFees	3055000	usd
CY2022Q1	us-gaap	Legal Fees LegalFees	524000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	323000	usd
CY2022Q1	nxdt	Conversion Expense ConversionExpense	363000	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	163000	usd
CY2022Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	46000	usd
CY2022Q1	us-gaap	Investment Company Shareholder Service Fee Expense InvestmentCompanyShareholderServiceFeeExpense	68000	usd
CY2022Q1	us-gaap	Trustee Fees TrusteeFees	68000	usd
CY2022Q1	nxdt	Audit And Tax Preparation Fees AuditAndTaxPreparationFees	38000	usd
CY2022Q1	us-gaap	Noninterest Expense Transfer Agent And Custodian Fees NoninterestExpenseTransferAgentAndCustodianFees	30000	usd
CY2022Q1	nxdt	Pricing Fees PricingFees	26000	usd
CY2022Q1	us-gaap	Investment Company Registration Expense InvestmentCompanyRegistrationExpense	26000	usd
CY2022Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	192000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	4922000	usd
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	9793000	usd
CY2022Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1155000	usd
CY2022Q1	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	49638000	usd
CY2022Q1	nxdt	Period Increase Decrease In Net Assets Resulting From Operations PeriodIncreaseDecreaseInNetAssetsResultingFromOperations	58276000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1017832000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20676000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1155000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	5575000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	0.34375
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1155000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	991581000	usd
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	9793000	usd
CY2022Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1155000	usd
CY2022Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	27591000	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	22047000	usd
CY2022Q1	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	58276000	usd
CY2022Q1	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	5566000	usd
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	5566000	usd
CY2022Q1	nxdt	Investment Company Net Assets From Operations And Dividends Increase Decrease InvestmentCompanyNetAssetsFromOperationsAndDividendsIncreaseDecrease	52710000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1526000	usd
CY2022Q1	nxdt	Net Increase Decrease From Shares Transactions NetIncreaseDecreaseFromSharesTransactions	1973000	usd
CY2022Q1	us-gaap	Investment Company Net Assets Period Increase Decrease InvestmentCompanyNetAssetsPeriodIncreaseDecrease	54683000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	911208000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	965891000	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	46000	shares
CY2022Q1	nxdt	Net Increase Decrease In Common Shares NetIncreaseDecreaseInCommonShares	46000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-19521000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3524000	usd
CY2023Q1	nxdt	Amortization Of Intangible Lease Liabilities AmortizationOfIntangibleLeaseLiabilities	-371000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	474000	usd
CY2023Q1	nxdt	Paid In Kind Interest Operating Activity PaidInKindInterestOperatingActivity	1008000	usd
CY2023Q1	nxdt	Realized Investment Gains Losses Including Noncash Amounts RealizedInvestmentGainsLossesIncludingNoncashAmounts	1135000	usd
CY2023Q1	nxdt	Unrealized Gain Loss On Investments Including Noncash Amounts UnrealizedGainLossOnInvestmentsIncludingNoncashAmounts	18640000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-76000	usd
CY2023Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	727000	usd
CY2023Q1	nxdt	Payments For Life Settlement Premiums PaymentsForLifeSettlementPremiums	1266000	usd
CY2023Q1	nxdt	Increase Decrease In Deferred Tax Asset IncreaseDecreaseInDeferredTaxAsset	-116000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	921000	usd
CY2023Q1	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	877000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	-476000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1793000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	505000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	14549000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1464000	usd
CY2023Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	4851000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	8234000	usd
CY2023Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	591000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	6397000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	2999000	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	8285000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	379000	usd
CY2023Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	1155000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	5575000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12587000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3848000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	48649000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	44801000	usd
CY2023Q1	us-gaap	Dividends And Interest Paid DividendsAndInterestPaid	2504000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	1501000	usd
CY2023Q1	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	322000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	58276000	usd
CY2022Q1	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	89000	usd
CY2022Q1	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-684000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-421000	usd
CY2022Q1	us-gaap-supplement	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	511000	usd
CY2022Q1	us-gaap	Increase Decrease In Payables To Broker Dealers IncreaseDecreaseInPayablesToBrokerDealers	6902000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	49000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	47093000	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-10000000	usd
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	5119000	usd
CY2022Q1	nxdt	Proceeds From Issuance Of Common Stock Excluding Subscriptions Receivable ProceedsFromIssuanceOfCommonStockExcludingSubscriptionsReceivable	1498000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13621000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	33472000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2678000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	36150000	usd
CY2022Q1	nxdt	Reinvestment Of Distributions ReinvestmentOfDistributions	447000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	312000	usd
CY2023Q1	nxdt	Advisory Agreement Term AdvisoryAgreementTerm	P3Y
CY2023Q1	nxdt	Advisory Agreement Additional Term AdvisoryAgreementAdditionalTerm	P1Y
CY2023Q1	us-gaap	Financial Designation Predecessor And Successor Fixed List FinancialDesignationPredecessorAndSuccessorFixedList	Successor
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates and Assumptions</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements are presented in accordance with GAAP which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the dates of the unaudited consolidated financial statements and the amounts of revenues and expenses during the reporting periods. Actual amounts realized or paid could differ from those estimates. All significant intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available fair market value, the fair value of the Company’s investments may fluctuate from period to period. Additionally, the fair value of investments may differ significantly from the values that would have been used had an active market existed for such investments and may differ materially from the values the Company may ultimately realize. Further, such investments may be subject to legal and other restrictions on resale or otherwise be less liquid than publicly traded securities.</span></div>
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	900000	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	100000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023Q1	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	126000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	471000	usd
CY2023Q1	nxdt	Deferred Tax Assets Operating Loss Carryforwards Utilized DeferredTaxAssetsOperatingLossCarryforwardsUtilized	30000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	16596000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17163000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14800000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2363000	usd
CY2023Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	4	property
CY2023Q1	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	271644000	usd
CY2023Q1	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	9489000	usd
CY2023Q1	us-gaap	Sec Schedule Iii Real Estate Investment Property Net SECScheduleIIIRealEstateInvestmentPropertyNet	262155000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	2100000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	152078000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	13250000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	usd
CY2023Q1	us-gaap	Long Term Debt Maturing In Years Four And Five LongTermDebtMaturingInYearsFourAndFive	0	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	165328000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	69852000	usd
CY2023Q1	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	41512000	usd
CY2023Q1	us-gaap	Equity Method Investment Difference Between Carrying Amount And Underlying Equity EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity	28340000	usd
CY2023Q1	nxdt	Equity Method Investment Share Of Earnings Loss EquityMethodInvestmentShareOfEarningsLoss	459000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	70656000	usd
CY2022Q4	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	49863000	usd
CY2022Q4	us-gaap	Equity Method Investment Difference Between Carrying Amount And Underlying Equity EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity	20793000	usd
CY2022	nxdt	Equity Method Investment Share Of Earnings Loss EquityMethodInvestmentShareOfEarningsLoss	501000	usd
CY2023Q1	nxdt	Equity Method Investments And Other Investments At Fair Value EquityMethodInvestmentsAndOtherInvestmentsAtFairValue	510592000	usd
CY2023Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	903240000	usd
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	914183000	usd
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Method Number Of Contracts LifeSettlementContractsFairValueMethodNumberOfContracts	28	contract
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Method Face Value LifeSettlementContractsFairValueMethodFaceValue	142952000	usd
CY2023Q1	nxdt	Life Settlement Contracts Fair Value Method Acquisition Cost LifeSettlementContractsFairValueMethodAcquisitionCost	48132000	usd
CY2023Q1	nxdt	Life Settlement Contracts Fair Value Method Premium Cost LifeSettlementContractsFairValueMethodPremiumCost	4006000	usd
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Method Carrying Amount LifeSettlementContractsFairValueMethodCarryingAmount	66384000	usd
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Method Number Of Contracts Maturing In Next Rolling Twelve Months LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextRollingTwelveMonths	0	contract
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Method Face Value Maturing In Next Rolling Twelve Months LifeSettlementContractsFairValueMethodFaceValueMaturingInNextRollingTwelveMonths	0	usd
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Maturing In Next Rolling Twelve Months LifeSettlementContractsFairValueMaturingInNextRollingTwelveMonths	0	usd
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Method Number Of Contracts Maturing In Rolling Year Two LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRollingYearTwo	3	contract
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Method Face Value Maturing In Rolling Year Two LifeSettlementContractsFairValueMethodFaceValueMaturingInRollingYearTwo	10351000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Maturing In Rolling Year Two LifeSettlementContractsFairValueMaturingInRollingYearTwo	7406000	usd
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Method Number Of Contracts Maturing In Rolling Year Three LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRollingYearThree	10	contract
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Method Face Value Maturing In Rolling Year Three LifeSettlementContractsFairValueMethodFaceValueMaturingInRollingYearThree	49412000	usd
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Maturing In Rolling Year Three LifeSettlementContractsFairValueMaturingInRollingYearThree	29685000	usd
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Method Number Of Contracts Maturing In Rolling Year Four LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRollingYearFour	3	contract
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Method Face Value Maturing In Rolling Year Four LifeSettlementContractsFairValueMethodFaceValueMaturingInRollingYearFour	21000000	usd
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Maturing In Rolling Year Four LifeSettlementContractsFairValueMaturingInRollingYearFour	10815000	usd
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Method Number Of Contracts Maturing In Rolling Year Five LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRollingYearFive	3	contract
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Method Face Value Maturing In Rolling Year Five LifeSettlementContractsFairValueMethodFaceValueMaturingInRollingYearFive	17100000	usd
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Maturing In Rolling Year Five LifeSettlementContractsFairValueMaturingInRollingYearFive	8160000	usd
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Method Number Of Contracts Maturing After Rolling Year Five LifeSettlementContractsFairValueMethodNumberOfContractsMaturingAfterRollingYearFive	9	contract
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Method Face Value Maturing After Rolling Year Five LifeSettlementContractsFairValueMethodFaceValueMaturingAfterRollingYearFive	45089000	usd
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Maturing After Rolling Year Five LifeSettlementContractsFairValueMaturingAfterRollingYearFive	10318000	usd
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Method Number Of Contracts LifeSettlementContractsFairValueMethodNumberOfContracts	28	contract
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Method Face Value LifeSettlementContractsFairValueMethodFaceValue	142952000	usd
CY2023Q1	us-gaap	Life Settlement Contracts Fair Value Method Carrying Amount LifeSettlementContractsFairValueMethodCarryingAmount	66384000	usd
CY2023Q1	nxdt	Life Settlement Contracts Payable Remainder Of Fiscal Year LifeSettlementContractsPayableRemainderOfFiscalYear	4006000	usd
CY2023Q1	nxdt	Life Settlement Contracts Payable In Rolling Year One LifeSettlementContractsPayableInRollingYearOne	5768000	usd
CY2023Q1	nxdt	Life Settlement Contracts Payable In Rolling Year Two LifeSettlementContractsPayableInRollingYearTwo	6291000	usd
CY2023Q1	nxdt	Life Settlement Contracts Payable In Rolling Year Three LifeSettlementContractsPayableInRollingYearThree	7004000	usd
CY2023Q1	nxdt	Life Settlement Contracts Payable In Rolling Year Four LifeSettlementContractsPayableInRollingYearFour	7675000	usd
CY2023Q1	nxdt	Life Insurance Policies Purchased Number LifeInsurancePoliciesPurchasedNumber	0	policy
CY2023Q1	nxdt	Life Insurance Policies Matured Number LifeInsurancePoliciesMaturedNumber	0	policy
CY2023Q1	nxdt	Life Insurance Policies Matured Premiums LifeInsurancePoliciesMaturedPremiums	1300000	usd
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37171807	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	nxdt	Stock Issued During Period Shares Pursuant To Dividend Reimbursement Plan That Was Terminated StockIssuedDuringPeriodSharesPursuantToDividendReimbursementPlanThatWasTerminated	0	shares
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20676000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37171807	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37171807	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2023Q1	nxdt	Annual Advisory Fee Percent AnnualAdvisoryFeePercent	0.0100
CY2023Q1	nxdt	Administrative Fee Percent AdministrativeFeePercent	0.0020
CY2023Q1	nxdt	Annual Advisory Fee Percent AnnualAdvisoryFeePercent	0.0100
CY2023Q1	nxdt	Administrative Fee Percent AdministrativeFeePercent	0.0020
CY2023Q1	nxdt	Advisory Agreement Maximum Monthly Fee AdvisoryAgreementMaximumMonthlyFee	1000000	usd
CY2023Q1	nxdt	Advisory Agreement Maximum Common Shares Issuable Percent AdvisoryAgreementMaximumCommonSharesIssuablePercent	0.05
CY2023Q1	nxdt	Advisory Agreement Maximum Voting Power Issuable Percent AdvisoryAgreementMaximumVotingPowerIssuablePercent	0.05
CY2023Q1	nxdt	Advisory Agreement Maximum Monthly Fee AdvisoryAgreementMaximumMonthlyFee	1000000	usd
CY2023Q1	nxdt	Advisory Agreement Threshold Trading Days AdvisoryAgreementThresholdTradingDays	P10D
CY2023Q1	nxdt	Maximum Fee Percentage Of Managed Assets MaximumFeePercentageOfManagedAssets	0.015
CY2023Q1	nxdt	Advisory Agreement Term AdvisoryAgreementTerm	P3Y
CY2023Q1	nxdt	Advisory Agreement Additional Term AdvisoryAgreementAdditionalTerm	P1Y
CY2023Q1	nxdt	Advisory Agreement Termination Threshold With Cause AdvisoryAgreementTerminationThresholdWithCause	P30D
CY2023Q1	nxdt	Advisory Agreement Termination Threshold Without Cause AdvisoryAgreementTerminationThresholdWithoutCause	P180D
CY2023Q1	nxdt	Advisory Agreement Termination Threshold Material Breach Of Contract AdvisoryAgreementTerminationThresholdMaterialBreachOfContract	P30D
CY2023Q1	nxdt	Advisory Agreement Material Breach Of Contract Term AdvisoryAgreementMaterialBreachOfContractTerm	P30D
CY2023Q1	nxdt	Termination Fee Calculation Threshold Period TerminationFeeCalculationThresholdPeriod	P1Y
CY2023Q1	nxdt	Administrative And Advisory Fees Expense AdministrativeAndAdvisoryFeesExpense	3600000	usd
CY2023Q1	nxdt	Deferred Expense To Comply With Cap DeferredExpenseToComplyWithCap	400000	usd
CY2023Q1	nxdt	Maximum Fee Percentage Of Managed Assets MaximumFeePercentageOfManagedAssets	0.015
CY2022Q4	nxdt	Noncontrolling Interest Shares Redeemed NoncontrollingInterestSharesRedeemed	2100000	shares
CY2022Q4	nxdt	Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests	2100000	shares
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	7369000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	6398000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6089000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4773000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3959000	usd
CY2023Q1	nxdt	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	3308000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	31896000	usd

Files In Submission

Name	View Source	Status
nxdt-20230331_cal.xml	Edgar Link	unprocessable
0001356115-23-000007-index-headers.html	Edgar Link	pending
0001356115-23-000007-index.html	Edgar Link	pending
0001356115-23-000007.txt	Edgar Link	pending
0001356115-23-000007-xbrl.zip	Edgar Link	pending
a103formofrsuawardagreemen.htm	Edgar Link	pending
a104formofrsuawardagreemen.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nxdt-20230331.htm	Edgar Link	pending
nxdt-20230331.xsd	Edgar Link	pending
nxdt-20230331xexx311.htm	Edgar Link	pending
nxdt-20230331xexx312.htm	Edgar Link	pending
nxdt-20230331xexx321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
nxdt-20230331_def.xml	Edgar Link	unprocessable
nxdt-20230331_lab.xml	Edgar Link	unprocessable
nxdt-20230331_pre.xml	Edgar Link	unprocessable
nxdt-20230331_htm.xml	Edgar Link	completed
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NXDT
NEXPOINT DIVERSIFIED REAL ESTATE TRUST Stock $nxdt

2023 Q2 Form 10-Q Financial Statement

#000135611523000007 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NXDT NEXPOINT DIVERSIFIED REAL ESTATE TRUST Stock $nxdt

2023 Q2 Form 10-Q Financial Statement

#000135611523000007 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NXDT
NEXPOINT DIVERSIFIED REAL ESTATE TRUST Stock $nxdt